Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XOMAP | US
0
0%
Healthcare
Biotechnology
30/06/2024
24/04/2026
26.13
26.13
26.13
26.13
XOMA Corporation operates as a biotech royalty aggregator in Europe the United States and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville California.
View LessPositive Momentum
Low 6-Month Volatility (<30%)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
24.8%1 month
23.3%3 months
14.0%6 months
14.2%26.27
-
-
1.22
0.50
-
-
-
-19.10M
-
-
8.20
-9.73
37.00
568.60
-17.35
3.48
0.01
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.61
Range1M
1.55
Range3M
1.74
Rel. volume
0.12
Price X volume
5.28K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.4278 | 0 | -0.44% | 25.57 | 121.93% |
| Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0 | 0 | -100.00% | n/a | 113.12% |
| SABSW | SABSW | Biotechnology | 0.0185 | 0 | 0.17 | 11.58% | |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 4.43 | 0 | 3.02% | n/a | 5.40% |
| REVBW | REVBW | Biotechnology | 0.0092 | 0 | n/a | 0.00% | |
| Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.17 | 0 | -2.50% | n/a | 1.72% |
| JSPRW | JSPRW | Biotechnology | 0.0155 | 0 | n/a | 2.31% | |
| ICUCW | ICUCW | Biotechnology | 0.0298 | 0 | 49.75% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.0868 | 0 | -1.48% | n/a | -63.37% |
| EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 35.5287 | 0 | 0.13% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | 26.27 | 41.03 | Cheaper |
| Price to Book | - | 15.55 | - |
| Dividend Yield | 8.20 | 2.20 | Leader |
| Std. Deviation (3M) | 14.03 | 72.80 | Lower Risk |
| Debt to Equity | 1.22 | -1.23 | Expensive |
| Debt to Assets | 0.50 | 0.25 | Expensive |
| Market Cap | - | 3.66B | - |